Skip to main content

and
  1. Article

    Open Access

    Influence of AFP on surgical outcomes in non-B non-C patients with curative resection for hepatocellular carcinoma

    To study the clinical and prognostic features of non-B non-C alpha-fetoprotein (AFP)(-)-hepatocellular carcinoma (HCC) (NBNC-AFP(-)-HCC) and the relationship between the prognostic features of HCC and hepatiti...

    ** Tan, Kai Zhou, Qing-li Zeng, Yun-fei Yuan in Clinical and Experimental Medicine (2023)

  2. No Access

    Article

    Lymphoid enhancer-binding factor-1 promotes stemness and poor differentiation of hepatocellular carcinoma by directly activating the NOTCH pathway

    The poorly differentiated hepatocellular carcinoma (HCC) cells are usually characterized by immature hepatic progenitor cell-like properties, such as enhanced self-renewal ability, resistance to chemotherapeut...

    Shuo Fang, Ming Liu, Lei Li, Fei-Fei Zhang, Yun Li, Qian Yan, Yu-Zhu Cui in Oncogene (2019)

  3. No Access

    Article

    Checkpoint kinase 1 is negatively regulated by miR-497 in hepatocellular carcinoma

    Checkpoint kinase 1 (CHEK1) is an evolutionarily conserved Ser/Thr kinase, which mediates cell-cycle arrest after DNA damage, and we previously reported that CHEK1 was overexpressed and associated with poor pr...

    Yin **e, Rong-Rong Wei, Guo-Liang Huang, Mei-Yin Zhang, Yun-Fei Yuan in Medical Oncology (2014)

  4. No Access

    Article

    Randomized study of chemoembolization as an adjuvant therapy for primary liver carcinoma after hepatectomy

    From April 1990 to December 1993, 140 patients were recruited to a randomized study to evaluate transcatheter hepatic arterial chemoembolization (TACE) as an adjuvant therapy for primary liver carcinoma after ...

    **-qing Li, Ya-qi Zhang, Wei-zhang Zhang in Journal of Cancer Research and Clinical On… (1995)